Dnatrix
Houston, US · Delaware corporation · 2 known investors
Founders & leadership
FT
Frank TufaroExecutive
BM
Brian MooneyNamed on SEC filing
IC
Isaac ChengNamed on SEC filing
RM
Reenie McCarthyNamed on SEC filing
Board
DW
Daniel WatkinsBoard director
DP
Drew PardollBoard director
FP
Francis Patrick McCormickBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$28.3M disclosed across 2 rounds · 2014–2018
▶$15.5MraisedSep 2018 · 40 investors · BiotechnologyRule 506(b)
▶$15.5MraisedSep 2018 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Drew PardollDirector
- Brian MooneyExecutive Officer
- Daniel WatkinsDirector
- Francis Patrick McCormickDirector
- Frank TufaroExecutive Officer, Director
- Isaac ChengDirector
- Offering amount
- $41.2M
- Amount sold
- $15.5M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.8MraisedOct 2014 · 31 investors · BiotechnologyRule 506(b)
▶$12.8MraisedOct 2014 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank TufaroExecutive Officer, Director
- Daniel WatkinsExecutive Officer, Director
- Francis Patrick McCormickDirector
- Reenie McCarthyDirector
- Offering amount
- $18.8M
- Amount sold
- $12.8M
- Minimum investment
- $25.5K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $852.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2014 | $160.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Dnatrix's investors?
- Dnatrix's investors include Targeted Technology Funds, Texas Ventures.
- How much funding has Dnatrix raised?
- Dnatrix has disclosed $28.3M raised across 2 rounds.
- Where is Dnatrix headquartered?
- Dnatrix is headquartered in Houston, US.